Transcriptome Identifies Mechanisms of 1 Regulatory T cell ( Treg ) Suppression of Acute Graft-versus-Host-Disease 2 3

[1]  Chuan-Yuan Li,et al.  Targeting Glycolysis in Alloreactive T Cells to Prevent Acute Graft-Versus-Host Disease While Preserving Graft-Versus-Leukemia Effect , 2022, Frontiers in Immunology.

[2]  H. von Bernuth,et al.  Adoptive transfer of ex vivo expanded regulatory T-cells improves immune cell engraftment and therapy-refractory chronic GvHD. , 2022, Molecular therapy : the journal of the American Society of Gene Therapy.

[3]  W. Cui,et al.  Single-cell immune profiling reveals a developmentally distinct CD4+ GM-CSF+ T-cell lineage that induces GI tract GVHD , 2022, Blood advances.

[4]  A. Shalek,et al.  Identification and Tracking of Alloreactive T Cell Clones in Rhesus Macaques Through the RM-scTCR-Seq Platform , 2021, bioRxiv.

[5]  J. Rathmell,et al.  Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease , 2021, Frontiers in Immunology.

[6]  B. Falini,et al.  Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia. , 2021, Blood advances.

[7]  E. L. Potter,et al.  Spatiotemporal single-cell profiling reveals that invasive and tissue-resident memory donor CD8+ T cells drive gastrointestinal acute graft-versus-host disease , 2021, Science Translational Medicine.

[8]  M. Boerries,et al.  Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans , 2020, Science Translational Medicine.

[9]  W. Linehan,et al.  Glycolytic metabolism of pathogenic T cells enables early detection of GvHD by 13C-MRI , 2020 .

[10]  Marc Ansari,et al.  Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantation , 2019, Leukemia.

[11]  Mark M. Davis,et al.  Opposing T Cell Responses in Experimental Autoimmune Encephalomyelitis , 2019, Nature.

[12]  R. Negrin.  Immune regulation in hematopoietic cell transplantation , 2019, Bone Marrow Transplantation.

[13]  G. Hill,et al.  Immune regulatory cell infusion for graft-versus-host disease prevention and therapy. , 2018, Blood.

[14]  J. Serody,et al.  A colitogenic memory CD4+ T cell population mediates gastrointestinal graft-versus-host disease. , 2016, The Journal of clinical investigation.

[15]  Lior Pachter,et al.  Near-optimal probabilistic RNA-seq quantification , 2016, Nature Biotechnology.

[16]  C. Le,et al.  Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect. , 2016, Blood.

[17]  R. Negrin.  Graft-versus-host disease versus graft-versus-leukemia. , 2015, Hematology. American Society of Hematology. Education Program.

[18]  M. Florek,et al.  Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease , 2015, The Journal of Immunology.

[19]  J. Pardo,et al.  Granzyme A Is Required for Regulatory T-Cell Mediated Prevention of Gastrointestinal Graft-versus-Host Disease , 2015, PloS one.

[20]  J. Rathmell,et al.  The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function. , 2014, Cell metabolism.

[21]  Mark M Davis,et al.  Linking T-cell receptor sequence to functional phenotype at the single-cell level , 2014, Nature Biotechnology.

[22]  J. Melenhorst,et al.  Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity , 2014, Clinical Cancer Research.

[23]  J. Ritz,et al.  Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease , 2013, Science Translational Medicine.

[24]  R. Geffers,et al.  Human regulatory T cells in allogeneic stem cell transplantation. , 2011, Blood.

[25]  G. Hill,et al.  CD4+CD25+ regulatory T cells control CD8+ T-cell effector differentiation by modulating IL-2 homeostasis , 2011, Proceedings of the National Academy of Sciences.

[26]  B. Falini,et al.  Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. , 2011, Blood.

[27]  J. Wagner,et al.  Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. , 2011, Blood.

[28]  A. Liston,et al.  Regulatory T Cells , 2011, Methods in Molecular Biology.

[29]  T. Ley,et al.  Granzyme B is not required for regulatory T cell-mediated suppression of graft-versus-host disease. , 2010, Blood.

[30]  Z. Berneman,et al.  Regulatory T Cells and Human Disease , 2008, Clinical & developmental immunology.

[31]  S. Ishihara,et al.  CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation–mediated apoptosis of effector CD4+ T cells , 2007, Nature Immunology.

[32]  C. Contag,et al.  In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation. , 2007, Blood.

[33]  C. Contag,et al.  In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. , 2005, Blood.

[34]  J. Serody,et al.  L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. , 2004, Blood.

[35]  Christopher H Contag,et al.  Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. , 2003, Blood.

[36]  C. Fathman,et al.  Donor-type CD4+CD25+ Regulatory T Cells Suppress Lethal Acute Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation , 2002, The Journal of experimental medicine.